Clinical trials: the sensitizing side of ONYX-015.
Wildner
O
O
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D012509:Sarcoma / Q000235:genetics / Q000628:therapy*; D014765:Viral Vaccines
D000970:Antineoplastic Agents; D014765:Viral Vaccines; C464532:dl1520